Clinical Trial Update: Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of tavilermide ophthalmic solution for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Keratoconjunctivitis Sicca

Drugs mentioned

• Tavilermide ophthalmic solution (tavilermide)

Snippet

Sponsor: Mimetogen Pharmaceuticals USA, Inc. | Conditions: Dry Eye Syndromes, Dry Eye Disease | Phase 3 | Status: COMPLETED